Article
Leveraging Artificial Intelligence for Decision-Making in Pediatric Progressive and Refractory Solid Tumors.
2024-12-09
Abstract excerpt
<h4>Background: </h4> Pediatric patients with progressive and refractory solid tumors face a challenging prognosis. Despite advancements in treatments like immunotherapy and targeted therapy, survival rates remain low for certain tumor types. Decision-making in these complex cases often necessitates a multidisciplinary approach, integrating risk-based management, precision medicine, and access to clinical trials....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5945ae8-510c-5d57-b738-cdab9274599c
- DOI
- 10.22541/au.173374584.44304130/v1
